| Programs | Development | Regulatory Submission | Regulatory Approval | |
|---|---|---|---|---|
| RSQ-777 | Nasal Diuretic | ||||
Regulatory Submission | ||||
| RSQ-786 | Subcutaneous Diuretic (Auto Injector) | ||||
Development | ||||
| RSQ-789 | Subcutaneous Diuretic (Smart Infusion System) | ||||
Development | ||||
| RSQ-781 | Veterinary Diuretic Spray | ||||
Development | ||||
| Programs | ||
|---|---|---|
| Development | Regulatory Submission | Regulatory Approval |
| RSQ-777 | Nasal Diuretic | ||
| RSQ-786 | Subcutaneous Diuretic (Auto Injector) | ||
| RSQ-789 | Subcutaneous Diuretic (Smart Infusion System) | ||
| RSQ-781 | Veterinary Diuretic Spray | ||
Corstasis Therapeutics’ products, including RSQ-777 and related investigational therapies, are under clinical investigation and have not been approved by regulatory authorities, including the U.S. Food and Drug Administration (FDA) or equivalent global agencies. Their safety, efficacy, and clinical use have not been established. All information provided is intended for educational and informational purposes only and should not be construed as medical advice or a recommendation for use. For questions about medical conditions or treatment options, please consult a qualified healthcare professional.